Francesc Artigas - Publications

Affiliations: 
Barcelona Biomedical Research Institute, Barcelona, Catalunya, Spain 
Area:
Neuropharmacology

190/363 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 López-Terrones E, Paz V, Campa L, Conde-Berriozabal S, Masana M, Artigas F, Riga MS. Differential Modulation of Dorsal Raphe Serotonergic Activity in Rat Brain by the Infralimbic and Prelimbic Cortices. International Journal of Molecular Sciences. 24. PMID 36902322 DOI: 10.3390/ijms24054891  0.474
2022 López-Terrones E, Celada P, Riga MS, Artigas F. Preferential In Vivo Inhibitory Action of Serotonin in Rat Infralimbic versus Prelimbic Cortex: Relevance for Antidepressant Treatments. Cerebral Cortex (New York, N.Y. : 1991). 32: 3000-3013. PMID 35848862 DOI: 10.1093/cercor/bhab396  0.504
2022 Cathala A, Lucas G, López-Terrones E, Revest JM, Artigas F, Spampinato U. Differential expression of serotonin receptors in GABAergic and serotoninergic neurons of the rat and mouse dorsal raphe nucleus. Molecular and Cellular Neurosciences. 103750. PMID 35697176 DOI: 10.1016/j.mcn.2022.103750  0.566
2022 Miquel-Rio L, Alarcón-Arís D, Torres-López M, Cóppola-Segovia V, Pavia-Collado R, Paz V, Ruiz-Bronchal E, Campa L, Casal C, Montefeltro A, Vila M, Artigas F, Revilla R, Bortolozzi A. Human α-synuclein overexpression in mouse serotonin neurons triggers a depressive-like phenotype. Rescue by oligonucleotide therapy. Translational Psychiatry. 12: 79. PMID 35210396 DOI: 10.1038/s41398-022-01842-z  0.427
2022 Castañé A, Riga MS, Cano M, Ruiz-Avila L, Miquel-Rio L, Celada P, Artigas F. The dual 5-HT3 and 5-HT6 receptor antagonist FPPQ normalizes phencyclidine-induced disruption of brain oscillatory activity in rats. The International Journal of Neuropsychopharmacology. PMID 35022720 DOI: 10.1093/ijnp/pyac003  0.518
2020 Riga MS, Sanchez C, Celada P, Artigas F. Sub-chronic vortioxetine (but not escitalopram) normalizes brain rhythm alterations and memory deficits induced by serotonin depletion in rats. Neuropharmacology. 108238. PMID 32750446 DOI: 10.1016/j.neuropharm.2020.108238  0.337
2020 Fullana N, Gasull-Camós J, Tarrés-Gatius M, Castañé A, Bortolozzi A, Artigas F. Astrocyte control of glutamatergic activity: Downstream effects on serotonergic function and emotional behavior. Neuropharmacology. 166: 107914. PMID 32045742 DOI: 10.1016/j.neuropharm.2019.107914  0.408
2019 Amat-Foraster M, Celada P, Richter U, Jensen AA, Plath N, Artigas F, Herrik KF. Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat. Neuropharmacology. 107745. PMID 31445017 DOI: 10.1016/J.Neuropharm.2019.107745  0.345
2019 Fullana MN, Ruiz-Bronchal E, Ferrés-Coy A, Juárez-Escoto E, Artigas F, Bortolozzi A. Regionally selective knockdown of astroglial glutamate transporters in infralimbic cortex induces a depressive phenotype in mice. Glia. PMID 30635928 DOI: 10.1002/glia.23593  0.376
2019 Spampinato U, Cathala A, Devroye C, Revest J, Artigas F. Serotonin2B receptors exert a GABA-mediated inhibitory control on dorsal raphe nucleus serotonin neuron activity: a microdialysis study in the rat European Neuropsychopharmacology. 29: S232. DOI: 10.1016/j.euroneuro.2018.11.374  0.42
2018 Cathala A, Devroye C, Drutel G, Revest JM, Artigas F, Spampinato U. Serotonin receptors in the rat dorsal raphe nucleus exert a GABA-mediated tonic inhibitory control on serotonin neurons. Experimental Neurology. 311: 57-66. PMID 30257183 DOI: 10.1016/J.Expneurol.2018.09.015  0.634
2018 Fullana MN, Ferrés-Coy A, Ortega JE, Ruiz-Bronchal E, Paz V, Meana JJ, Artigas F, Bortolozzi A. Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression. Molecular Neurobiology. PMID 30088175 DOI: 10.1007/s12035-018-1288-1  0.388
2018 Gasull-Camós J, Martínez-Torres S, Tarrés-Gatius M, Ozaita A, Artigas F, Castañé A. Serotonergic mechanisms involved in antidepressant-like responses evoked by GLT-1 blockade in rat infralimbic cortex. Neuropharmacology. PMID 29940206 DOI: 10.1016/j.neuropharm.2018.06.029  0.525
2018 Amat-Foraster M, Jensen AA, Plath N, Herrik KF, Celada P, Artigas F. Temporally dissociable effects of ketamine on neuronal discharge and gamma oscillations in rat thalamo-cortical networks. Neuropharmacology. PMID 29702122 DOI: 10.1016/j.neuropharm.2018.04.022  0.303
2018 Artigas F, Celada P, Bortolozzi A. Can we increase the speed and efficacy of antidepressant treatments? Part II. Glutamatergic and RNA interference strategies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 28: 457-482. PMID 29525411 DOI: 10.1016/j.euroneuro.2018.01.005  0.349
2017 Riga MS, Lladó-Pelfort L, Artigas F, Celada P. The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors. Neuropharmacology. PMID 29221792 DOI: 10.1016/j.neuropharm.2017.11.049  0.374
2017 Artigas F, Analia Bortolozzi, Pau Celada. Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 29174531 DOI: 10.1016/j.euroneuro.2017.10.032  0.628
2017 van den Munkhof HE, Arnt J, Celada P, Artigas F. The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 29128144 DOI: 10.1016/j.euroneuro.2017.10.034  0.429
2017 Santana N, Artigas F. Laminar and Cellular Distribution of Monoamine Receptors in Rat Medial Prefrontal Cortex. Frontiers in Neuroanatomy. 11: 87. PMID 29033796 DOI: 10.3389/fnana.2017.00087  0.484
2017 Gasull-Camós J, Soto-Montenegro ML, Casquero-Veiga M, Desco M, Artigas F, Castañé A. Differential Patterns of Subcortical Activity Evoked by Glial GLT-1 Blockade in Prelimbic and Infralimbic Cortex: Relationship to Antidepressant-Like Effects in Rats. The International Journal of Neuropsychopharmacology. PMID 29016806 DOI: 10.1093/ijnp/pyx067  0.307
2017 Devroye C, Haddjeri N, Cathala A, Rovera R, Drago F, Piazza PV, Artigas F, Spampinato U. Opposite controls of mesocortical and mesoaccumbal dopamine pathways by serotonin2B receptor blockade: Involvement of medial prefrontal cortex serotonin1A receptors. Neuropharmacology. PMID 28390892 DOI: 10.1016/J.Neuropharm.2017.04.001  0.501
2017 Artigas F. Joint Symposium: How Long Do We Have to Wait for the Antidepressant Effect? Mechanisms of Action for Delay of Onset Response to Antidepressants European Psychiatry. 41: S3-S3. DOI: 10.1016/J.EURPSY.2017.01.017  0.552
2016 Riga MS, Teruel-Martí V, Sánchez C, Celada P, Artigas F. Subchronic vortioxetine treatment -but not escitalopram- enhances pyramidal neuron activity in the rat prefrontal cortex. Neuropharmacology. PMID 27671324 DOI: 10.1016/j.neuropharm.2016.09.024  0.544
2016 Santana N, Artigas F. Expression of Serotonin2C Receptors in Pyramidal and GABAergic Neurons of Rat Prefrontal Cortex: A Comparison with Striatum. Cerebral Cortex (New York, N.Y. : 1991). PMID 27252352 DOI: 10.1093/cercor/bhw148  0.39
2016 Riga MS, Sánchez C, Celada P, Artigas F. Involvement of 5-HT3 receptors in the action of vortioxetine in rat brain: Focus on glutamatergic and GABAergic neurotransmission. Neuropharmacology. PMID 27106166 DOI: 10.1016/j.neuropharm.2016.04.023  0.595
2016 Van den Munkhof H, Celada P, Artigas F. The novel antipsychotic brexpiprazole reverses a disruption of thalamocortical function induced by phencyclidine: exploring the involvement of 5-HT1A and ɑ1B-adrenergic receptors European Neuropsychopharmacology. 26: S128-S129. DOI: 10.1016/S0924-977X(16)30908-7  0.328
2015 Riga MS, Bortolozzi A, Campa L, Artigas F, Celada P. The serotonergic hallucinogen 5-methoxy-N,N-dimethyltryptamine disrupts cortical activity in a regionally-selective manner via 5-HT1A and 5-HT2A receptors. Neuropharmacology. 101: 370-378. PMID 26477571 DOI: 10.1016/j.neuropharm.2015.10.016  0.495
2015 Ferrés-Coy A, Galofré M, Pilar-Cuéllar F, Vidal R, Paz V, Ruiz-Bronchal E, Campa L, Pazos Á, Caso JR, Leza JC, Alvarado G, Montefeltro A, Valdizán EM, Artigas F, Bortolozzi A. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration. Molecular Psychiatry. PMID 26100539 DOI: 10.1038/mp.2015.80  0.324
2015 Castañé A, Kargieman L, Celada P, Bortolozzi A, Artigas F. 5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetine. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1353-61. PMID 25914158 DOI: 10.1016/j.euroneuro.2015.04.006  0.602
2015 Sanchez C, Asin KE, Artigas F. Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. Pharmacology & Therapeutics. 145: 43-57. PMID 25016186 DOI: 10.1016/j.pharmthera.2014.07.001  0.664
2015 Artigas F. Developments in the field of antidepressants, where do we go now? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 657-70. PMID 23706576 DOI: 10.1016/j.euroneuro.2013.04.013  0.536
2014 Alvarez E, Perez V, Artigas F. Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder. Neuropsychiatric Disease and Treatment. 10: 1297-307. PMID 25075188 DOI: 10.2147/NDT.S41387  0.5
2014 Riga MS, Soria G, Tudela R, Artigas F, Celada P. The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1269-82. PMID 24650558 DOI: 10.1017/S1461145714000261  0.351
2014 Mocci G, Jiménez-Sánchez L, Adell A, Cortés R, Artigas F. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action. Neuropharmacology. 79: 49-58. PMID 24211653 DOI: 10.1016/j.neuropharm.2013.10.021  0.44
2014 Bortolozzi A, Celada P, Artigas F. Novel therapeutic strategies in major depression: focus on RNAi and ketamine. Current Pharmaceutical Design. 20: 3848-60. PMID 24180396  0.336
2014 Cano-Colino M, Almeida R, Gomez-Cabrero D, Artigas F, Compte A. Serotonin regulates performance nonmonotonically in a spatial working memory network. Cerebral Cortex (New York, N.Y. : 1991). 24: 2449-63. PMID 23629582 DOI: 10.1093/Cercor/Bht096  0.528
2013 Celada P, Lladó-Pelfort L, Santana N, Kargieman L, Troyano-Rodriguez E, Riga MS, Artigas F. Disruption of thalamocortical activity in schizophrenia models: relevance to antipsychotic drug action. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 2145-63. PMID 23809188 DOI: 10.1017/S1461145713000643  0.419
2013 Celada P, Bortolozzi A, Artigas F. Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research. Cns Drugs. 27: 703-16. PMID 23757185 DOI: 10.1007/s40263-013-0071-0  0.53
2013 Celada P, Puig MV, Artigas F. Serotonin modulation of cortical neurons and networks. Frontiers in Integrative Neuroscience. 7: 25. PMID 23626526 DOI: 10.3389/fnint.2013.00025  0.763
2013 Artigas F. Future directions for serotonin and antidepressants. Acs Chemical Neuroscience. 4: 5-8. PMID 23336036 DOI: 10.1021/cn3001125  0.585
2013 Ferrés-Coy A, Pilar-Cuellar F, Vidal R, Paz V, Masana M, Cortés R, Carmona MC, Campa L, Pazos A, Montefeltro A, Valdizán EM, Artigas F, Bortolozzi A. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis. Translational Psychiatry. 3: e211. PMID 23321808 DOI: 10.1038/tp.2012.135  0.505
2013 Santana N, Mengod G, Artigas F. Expression of α(1)-adrenergic receptors in rat prefrontal cortex: cellular co-localization with 5-HT(2A) receptors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 1139-51. PMID 23195622 DOI: 10.1017/S1461145712001083  0.58
2013 Artigas F. Serotonin receptors involved in antidepressant effects. Pharmacology & Therapeutics. 137: 119-31. PMID 23022360 DOI: 10.1016/j.pharmthera.2012.09.006  0.665
2013 Ferrés-Coy A, Santana N, Castañé A, Cortés R, Carmona MC, Toth M, Montefeltro A, Artigas F, Bortolozzi A. Acute 5-HT₁A autoreceptor knockdown increases antidepressant responses and serotonin release in stressful conditions. Psychopharmacology. 225: 61-74. PMID 22820867 DOI: 10.1007/s00213-012-2795-9  0.495
2013 Riga M, Celada P, Sanchez C, Artigas F. P.2.e.003 Role of 5-HT3 receptors in the mechanism of action of the investigational antidepressant vortioxetine European Neuropsychopharmacology. 23: S393-S394. DOI: 10.1016/S0924-977X(13)70621-7  0.497
2012 Masana M, Castañé A, Santana N, Bortolozzi A, Artigas F. Noradrenergic antidepressants increase cortical dopamine: potential use in augmentation strategies. Neuropharmacology. 63: 675-84. PMID 22652058 DOI: 10.1016/j.neuropharm.2012.05.020  0.434
2012 Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P. In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat. Psychopharmacology. 221: 261-72. PMID 22147258 DOI: 10.1007/s00213-011-2569-9  0.514
2012 Scorza MC, Lladó-Pelfort L, Oller S, Cortés R, Puigdemont D, Portella MJ, Pérez-Egea R, Alvarez E, Celada P, Pérez V, Artigas F. Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment. British Journal of Pharmacology. 167: 1021-34. PMID 22050051 DOI: 10.1111/j.1476-5381.2011.01770.x  0.582
2012 Kargieman L, Riga MS, Artigas F, Celada P. Clozapine Reverses Phencyclidine-Induced Desynchronization of Prefrontal Cortex through a 5-HT(1A) Receptor-Dependent Mechanism. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 723-33. PMID 22012474 DOI: 10.1038/npp.2011.249  0.431
2012 Lladó-Pelfort L, Santana N, Ghisi V, Artigas F, Celada P. 5-HT1A receptor agonists enhance pyramidal cell firing in prefrontal cortex through a preferential action on GABA interneurons. Cerebral Cortex (New York, N.Y. : 1991). 22: 1487-97. PMID 21893679 DOI: 10.1093/cercor/bhr220  0.47
2012 Bortolozzi A, Castañé A, Semakova J, Santana N, Alvarado G, Cortés R, Ferrés-Coy A, Fernández G, Carmona MC, Toth M, Perales JC, Montefeltro A, Artigas F. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects. Molecular Psychiatry. 17: 612-23. PMID 21808255 DOI: 10.1038/mp.2011.92  0.485
2012 Alvarez E, Perez V, Dragheim M, Loft H, Artigas F. A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 589-600. PMID 21767441 DOI: 10.1017/S1461145711001027  0.425
2012 López-Gil X, Jiménez-Sánchez L, Romón T, Campa L, Artigas F, Adell A. Importance of inter-hemispheric prefrontal connection in the effects of non-competitive NMDA receptor antagonists. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 945-56. PMID 21733285 DOI: 10.1017/S1461145711001064  0.311
2011 Santana N, Troyano-Rodriguez E, Mengod G, Celada P, Artigas F. Activation of thalamocortical networks by the N-methyl-D-aspartate receptor antagonist phencyclidine: reversal by clozapine. Biological Psychiatry. 69: 918-27. PMID 21251645 DOI: 10.1016/j.biopsych.2010.10.030  0.368
2011 Vázquez-Borsetti P, Celada P, Cortés R, Artigas F. Simultaneous projections from prefrontal cortex to dopaminergic and serotonergic nuclei. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 289-302. PMID 20374686 DOI: 10.1017/S1461145710000349  0.398
2010 Lladó-Pelfort L, Assié MB, Newman-Tancredi A, Artigas F, Celada P. Preferential in vivo action of F15599, a novel 5-HT(1A) receptor agonist, at postsynaptic 5-HT(1A) receptors. British Journal of Pharmacology. 160: 1929-40. PMID 20649591 DOI: 10.1111/j.1476-5381.2010.00738.x  0.535
2010 Scorza MC, Castañé A, Bortolozzi A, Artigas F. Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801 Clz and MK-801 in KO1A mice. Neuropharmacology. 59: 112-20. PMID 20412811 DOI: 10.1016/j.neuropharm.2010.04.012  0.438
2010 Bortolozzi A, Masana M, Díaz-Mataix L, Cortés R, Scorza MC, Gingrich JA, Toth M, Artigas F. Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1299-314. PMID 20158933 DOI: 10.1017/S146114571000009X  0.53
2010 Artigas F. The prefrontal cortex: a target for antipsychotic drugs. Acta Psychiatrica Scandinavica. 121: 11-21. PMID 20059453 DOI: 10.1111/j.1600-0447.2009.01455.x  0.4
2010 López-Gil X, Artigas F, Adell A. Unraveling monoamine receptors involved in the action of typical and atypical antipsychotics on glutamatergic and serotonergic transmission in prefrontal cortex. Current Pharmaceutical Design. 16: 502-15. PMID 19909228 DOI: 10.2174/138161210790361416  0.55
2009 Vázquez-Borsetti P, Cortés R, Artigas F. Pyramidal neurons in rat prefrontal cortex projecting to ventral tegmental area and dorsal raphe nucleus express 5-HT2A receptors. Cerebral Cortex (New York, N.Y. : 1991). 19: 1678-86. PMID 19029064 DOI: 10.1093/cercor/bhn204  0.592
2009 López-Gil X, Artigas F, Adell A. Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 487-99. PMID 18752722 DOI: 10.1017/S1461145708009267  0.504
2009 Santana N, Mengod G, Artigas F. Quantitative analysis of the expression of dopamine D1 and D2 receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 19: 849-60. PMID 18689859 DOI: 10.1093/cercor/bhn134  0.319
2008 Castañé A, Artigas F, Bortolozzi A. The absence of 5-HT(1A) receptors has minor effects on dopamine but not serotonin release evoked by MK-801 in mice prefrontal cortex. Psychopharmacology. 200: 281-90. PMID 18594799 DOI: 10.1007/s00213-008-1205-9  0.618
2008 Celada P, Puig MV, Díaz-Mataix L, Artigas F. The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs. Biological Psychiatry. 64: 392-400. PMID 18436196 DOI: 10.1016/j.biopsych.2008.03.013  0.581
2008 López-Gil J, Artigas F, Adell A. P.3.d.007 Monoamine receptors mediating clozapine and haloperidol action on glutamate and serotonin release in prefrontal cortex European Neuropsychopharmacology. 18: S452. DOI: 10.1016/S0924-977X(08)70668-0  0.35
2008 Lladó-Pelfort L, Artigas F, Celada P. P.1.c.034 Postsynaptic 5-HT1A receptors are involved in the excitatory action of 8-OH-DPAT on prefrontal cortex pyramidal neurons European Neuropsychopharmacology. 18: S239. DOI: 10.1016/S0924-977X(08)70298-0  0.381
2008 Santana N, De Almeida J, Mengod G, Artigas F. Localization of 5-HT receptors in the mammalian cortex Serotonin and Sleep: Molecular, Functional and Clinical Aspects. 135-153. DOI: 10.1007/978-3-7643-8561-3_5  0.572
2007 Kargieman L, Santana N, Mengod G, Celada P, Artigas F. Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine. Proceedings of the National Academy of Sciences of the United States of America. 104: 14843-8. PMID 17785415 DOI: 10.1073/pnas.0704848104  0.336
2007 Amargós-Bosch M, Adell A, Artigas F. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex. Journal of Neurochemistry. 102: 550-61. PMID 17394545 DOI: 10.1111/j.1471-4159.2007.04532.x  0.625
2007 López-Gil X, Babot Z, Amargós-Bosch M, Suñol C, Artigas F, Adell A. Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2087-97. PMID 17356574 DOI: 10.1038/sj.npp.1301356  0.545
2007 Bortolozzi A, Díaz-Mataix L, Toth M, Celada P, Artigas F. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain. Psychopharmacology. 191: 745-58. PMID 17265076 DOI: 10.1007/s00213-007-0698-y  0.591
2007 Castañé A, Bortolozzi A, Toth M, Artigas F. P.2.18 Cortical dopamine and serotonin release in a pharmacological model of schizophrenia. Involvement of 5-HT1A receptors European Neuropsychopharmacology. 17: S53-S54. DOI: 10.1016/S0924-977X(07)70063-9  0.338
2007 Celada P, Artigas F. Serotonin modulation of cortical activity Monoaminergic Modulation of Cortical Excitability. 67-89. DOI: 10.1007/978-0-387-72256-6_4  0.376
2006 Artigas F, Adell A, Celada P. Pindolol augmentation of antidepressant response. Current Drug Targets. 7: 139-47. PMID 16475955 DOI: 10.2174/138945006775515446  0.363
2006 Amargós-Bosch M, López-Gil X, Artigas F, Adell A. Clozapine and olanzapine, but not haloperidol, suppress serotonin efflux in the medial prefrontal cortex elicited by phencyclidine and ketamine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 9: 565-73. PMID 16316487 DOI: 10.1017/S1461145705005900  0.482
2006 Díaz-Mataix L, Artigas F, Celada P. Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by a 5-HT1A receptor agonist. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 288-96. PMID 16290106 DOI: 10.1016/j.euroneuro.2005.10.003  0.594
2006 Kargieman L, Celada P, Artigas F. Increased activity of prefrontal pyramidal neurons after phencyclidine administration: reversal by clozapine European Neuropsychopharmacology. 16: S50-S51. DOI: 10.1016/S0924-977X(06)80061-1  0.322
2006 Vázquez P, Celada P, Cortés R, Artigas F. Evidence of a simultaneous control of serotonergic and dopaminergic neurons by the medial prefrontal cortex European Neuropsychopharmacology. 16: S49. DOI: 10.1016/S0924-977X(06)80059-3  0.329
2005 Díaz-Mataix L, Scorza MC, Bortolozzi A, Toth M, Celada P, Artigas F. Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 10831-43. PMID 16306396 DOI: 10.1523/JNEUROSCI.2999-05.2005  0.461
2005 Bortolozzi A, Díaz-Mataix L, Scorza MC, Celada P, Artigas F. The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity. Journal of Neurochemistry. 95: 1597-607. PMID 16277612 DOI: 10.1111/j.1471-4159.2005.03485.x  0.625
2005 Amargós-Bosch M, Artigas F, Adell A. Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex. European Journal of Pharmacology. 516: 235-8. PMID 15967429 DOI: 10.1016/j.ejphar.2005.05.004  0.536
2005 Marek GJ, Martin-Ruiz R, Abo A, Artigas F. The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2205-15. PMID 15886717 DOI: 10.1038/sj.npp.1300762  0.56
2005 Adell A, Castro E, Celada P, Bortolozzi A, Pazos A, Artigas F. Strategies for producing faster acting antidepressants. Drug Discovery Today. 10: 578-85. PMID 15837601 DOI: 10.1016/S1359-6446(05)03398-2  0.315
2005 Puig MV, Artigas F, Celada P. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cerebral Cortex (New York, N.Y. : 1991). 15: 1-14. PMID 15238448 DOI: 10.1093/cercor/bhh104  0.653
2005 Bortolozzi A, Scorza M, Díaz-Mataix L, Celada E, Toth M, Artigas F. P.1.14 Modulation of the mesocortical dopaminergic system by prefrontal 5-HT1A receptors. Role in antipsychotic drug action European Neuropsychopharmacology. 15: S13-S14. DOI: 10.1016/S0924-977X(05)80119-1  0.313
2004 Puig MV, Celada P, Artigas F. [Serotonergic control of prefrontal cortex]. Revista De Neurologia. 39: 539-47. PMID 15467993  0.714
2004 Celada P, Puig M, Amargós-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. Journal of Psychiatry & Neuroscience : Jpn. 29: 252-65. PMID 15309042  0.714
2004 Adell A, Artigas F. The somatodendritic release of dopamine in the ventral tegmental area and its regulation by afferent transmitter systems. Neuroscience and Biobehavioral Reviews. 28: 415-31. PMID 15289006 DOI: 10.1016/j.neubiorev.2004.05.001  0.383
2004 Puig MV, Santana N, Celada P, Mengod G, Artigas F. In vivo excitation of GABA interneurons in the medial prefrontal cortex through 5-HT3 receptors. Cerebral Cortex (New York, N.Y. : 1991). 14: 1365-75. PMID 15166106 DOI: 10.1093/cercor/bhh097  0.733
2004 Santana N, Bortolozzi A, Serrats J, Mengod G, Artigas F. Expression of serotonin1A and serotonin2A receptors in pyramidal and GABAergic neurons of the rat prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 14: 1100-9. PMID 15115744 DOI: 10.1093/Cercor/Bhh070  0.556
2004 Bortolozzi A, Amargós-Bosch M, Toth M, Artigas F, Adell A. In vivo efflux of serotonin in the dorsal raphe nucleus of 5-HT1A receptor knockout mice. Journal of Neurochemistry. 88: 1373-9. PMID 15009637  0.533
2004 Amargós-Bosch M, Bortolozzi A, Puig MV, Serrats J, Adell A, Celada P, Toth M, Mengod G, Artigas F. Co-expression and in vivo interaction of serotonin1A and serotonin2A receptors in pyramidal neurons of prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 14: 281-99. PMID 14754868 DOI: 10.1093/Cercor/Bhg128  0.741
2004 Serrats J, Artigas F, Mengod G, Cortés R. An autoradiographic study of the influence of pindolol upon [35S]GTPgammaS binding in rat, guinea pig and human brain. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 7: 27-34. PMID 14720318 DOI: 10.1017/S1461145703003924  0.56
2004 Scorza M, Diaz-Mataix L, Bortolozzi A, Celada P, Artigas F. S.4.10 Modulation of mesocortical dopaminergic system by prefrontal 5-HT2 receptors. Effects of antipsychotic drugs European Neuropsychopharmacology. 14: S70. DOI: 10.1016/S0924-977X(04)90088-0  0.54
2004 Santana N, Puig M, Celada P, Mengod G, Artigas F. S.4.09 Endogenous serotonin excites GABAergic neurons of the rat prefrontal cortex through the activation of 5-HT3 receptors European Neuropsychopharmacology. 14: S69-S70. DOI: 10.1016/S0924-977X(04)90087-9  0.615
2004 Amargós-Bosch M, Adell A, Artigas F. S.4.01 Stimulation of α1-adrenergic and AMPA receptors in rat medial prefrontal cortex increases local in vivo serotonin release: reversal by antipsychotic drugs European Neuropsychopharmacology. 14: S63-S64. DOI: 10.1016/S0924-977X(04)90079-X  0.348
2003 Amargós-Bosch M, Adell A, Bortolozzi A, Artigas F. Stimulation of alpha1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: reversal by antipsychotic drugs. Journal of Neurochemistry. 87: 831-42. PMID 14622114  0.559
2003 Bortolozzi A, Amargós-Bosch M, Adell A, Díaz-Mataix L, Serrats J, Pons S, Artigas F. In vivo modulation of 5-hydroxytryptamine release in mouse prefrontal cortex by local 5-HT(2A) receptors: effect of antipsychotic drugs. The European Journal of Neuroscience. 18: 1235-46. PMID 12956722 DOI: 10.1046/J.1460-9568.2003.02829.X  0.423
2003 Puig MV, Celada P, Díaz-Mataix L, Artigas F. In vivo modulation of the activity of pyramidal neurons in the rat medial prefrontal cortex by 5-HT2A receptors: relationship to thalamocortical afferents. Cerebral Cortex (New York, N.Y. : 1991). 13: 870-82. PMID 12853374 DOI: 10.1093/cercor/13.8.870  0.746
2003 Messa C, Colombo C, Moresco RM, Gobbo C, Galli L, Lucignani G, Gilardi MC, Rizzo G, Smeraldi E, Zanardi R, Artigas F, Fazio F. 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study. Psychopharmacology. 167: 72-8. PMID 12632246 DOI: 10.1007/s00213-002-1379-5  0.404
2003 Romero L, Celada P, Martín-Ruiz R, Díaz-Mataix L, Mourelle M, Delgadillo J, Hervás I, Artigas F. Modulation of serotonergic function in rat brain by VN2222, a serotonin reuptake inhibitor and 5-HT1A receptor agonist. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 445-56. PMID 12629524 DOI: 10.1038/sj.npp.1300062  0.618
2003 Bortolozzi A, Artigas F. Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of alpha-adrenoceptors. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 421-34. PMID 12629522 DOI: 10.1038/sj.npp.1300061  0.522
2002 Celada P, Puig MV, Martín-Ruiz R, Casanovas JM, Artigas F. Control of the serotonergic system by the medial prefrontal cortex: potential role in the etiology of PTSD and depressive disorders. Neurotoxicity Research. 4: 409-419. PMID 12754155 DOI: 10.1080/10298420290030550  0.753
2002 Adell A, Celada P, Abellán MT, Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Research. Brain Research Reviews. 39: 154-80. PMID 12423765 DOI: 10.1016/S0165-0173(02)00182-0  0.654
2002 Celada P, Casanovas JM, Paez X, Artigas F. Control of serotonergic neurons in the dorsal raphe nucleus by the lateral hypothalamus. Brain Research. 932: 79-90. PMID 11911864 DOI: 10.1016/S0006-8993(02)02284-9  0.572
2002 Artigas F. Central and Peripheral 5-HT3 Receptors (Neuroscience Receptors Series, Vol. 4) edited by Michel Hamon. Academic Press, San Diego, ISBN 012-322-3709, 1992, 314 pp., $89.00. Journal of Neurochemistry. 62: 819-820. DOI: 10.1046/j.1471-4159.1994.t01-2-62020819.x  0.49
2002 Puig M, Celada P, Artigas F. Modulation of the activity of layer V pyramidal neurons in medial prefrontal cortex by 5-HT2A receptors. Potential role in antipsychotic drug action European Neuropsychopharmacology. 12: 91-92. DOI: 10.1016/S0924-977X(02)80020-7  0.377
2001 Artigas F. Limitations to enhancing the speed of onset of antidepressants - are rapid action antidepressants possible? Human Psychopharmacology. 16: 29-36. PMID 12404595 DOI: 10.1002/hup.180  0.415
2001 Celada P, Puig MV, Casanovas JM, Guillazo G, Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: Involvement of serotonin-1A, GABA(A), and glutamate receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 9917-29. PMID 11739599 DOI: 10.1523/Jneurosci.21-24-09917.2001  0.755
2001 Martín-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, Artigas F. Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 9856-66. PMID 11739593 DOI: 10.1523/Jneurosci.21-24-09856.2001  0.751
2001 Adell A, Celada P, Artigas F. The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain. Journal of Neurochemistry. 79: 172-82. PMID 11595769 DOI: 10.1046/j.1471-4159.2001.00550.x  0.637
2001 Artigas F, Celada P, Laruelle M, Adell A. How does pindolol improve antidepressant action? Trends in Pharmacological Sciences. 22: 224-8. PMID 11339972 DOI: 10.1016/S0165-6147(00)01682-5  0.65
2001 Martín-Ruiz R, Ugedo L, Honrubia MA, Mengod G, Artigas F. Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus. Journal of Neurochemistry. 77: 762-75. PMID 11331405 DOI: 10.1046/j.1471-4159.2001.00275.x  0.611
2001 Lucas G, Di Matteo V, De Deurwaerdère P, Porras G, Martín-Ruiz R, Artigas F, Esposito E, Spampinato U. Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function. The European Journal of Neuroscience. 13: 889-98. PMID 11264661 DOI: 10.1046/j.0953-816X.2000.01453.x  0.54
2001 Zanardi R, Artigas F, Moresco R, Colombo C, Messa C, Gobbo C, Smeraldi E, Fazio F. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. Journal of Clinical Psychopharmacology. 21: 53-8. PMID 11199948 DOI: 10.1097/00004714-200102000-00010  0.313
2001 Hervás I, Vilaró MT, Romero L, Scorza MC, Mengod G, Artigas F. Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 11-20. PMID 11106871 DOI: 10.1016/S0893-133X(00)00175-5  0.575
2000 Abellán MT, Martín-Ruiz R, Artigas F. Local modulation of the 5-HT release in the dorsal striatum of the rat: an in vivo microdialysis study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 10: 455-62. PMID 11115735 DOI: 10.1016/S0924-977X(00)00118-8  0.595
2000 Casanovas JM, Berton O, Celada P, Artigas F. In vivo actions of the selective 5-HT1A receptor agonist BAY x 3702 on serotonergic cell firing and release. Naunyn-Schmiedeberg's Archives of Pharmacology. 362: 248-54. PMID 10997727 DOI: 10.1007/s002100000291  0.524
2000 Goodnick PJ, Kumar AM, Artigas F, Perez V, Alvarez E. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression (multiple letters) Biological Psychiatry. 47: 846-847. PMID 10819459  0.388
2000 Abellán MT, Adell A, Honrubia MA, Mengod G, Artigas F. GABAB-RI receptors in serotonergic neurons: effects of baclofen on 5-HT output in rat brain. Neuroreport. 11: 941-5. PMID 10790860  0.64
2000 Hervás I, Queiroz CM, Adell A, Artigas F. Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat. British Journal of Pharmacology. 130: 160-6. PMID 10781012 DOI: 10.1038/sj.bjp.0703297  0.61
2000 Abellán MT, Jolas T, Aghajanian GK, Artigas F. Dual control of dorsal raphe serotonergic neurons by GABA(B) receptors. Electrophysiological and microdialysis studies. Synapse (New York, N.Y.). 36: 21-34. PMID 10700023 DOI: 10.1002/(SICI)1098-2396(200004)36:1<21::AID-SYN3>3.0.CO;2-D  0.572
2000 Gobbo C, Zanardi R, Messa C, Artigas F, Moresco RM, Colombo C, Rizzo G, Panzacchi A, Smeraldi E, Fazio F. 5-HT2 receptors in depressed patients studied by [F-18]FESP and PET: Effects of depressive symptoms Neuroimage. 11: S75.  0.329
1999 Bel N, Artigas F. Modulation of the extracellular 5-hydroxytryptamine brain concentrations by the serotonin and noradrenaline reuptake inhibitor, milnacipran. Microdialysis studies in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 21: 745-54. PMID 10633480 DOI: 10.1016/S0893-133X(99)00076-7  0.559
1999 Figueras G, Pérez V, San Martino O, Alvarez E, Artigas F. Pretreatment platelet 5-HT concentration predicts the short-term response to paroxetine in major depression. Grupo de Trastornos Afectivos. Biological Psychiatry. 46: 518-24. PMID 10459402 DOI: 10.1016/S0006-3223(98)00344-8  0.464
1999 Raurich A, Mengod G, Artigas F, Cortés R. Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain. Synapse (New York, N.Y.). 34: 68-76. PMID 10459173 DOI: 10.1002/(SICI)1098-2396(199910)34:1<68::AID-SYN8>3.0.CO;2-Z  0.488
1999 Ugedo L, Pineda J, Martín-Ruiz R, Ruiz-Ortega JA, Artigas F. Imidazoline-induced inhibition of firing rate of 5-HT neurons in rat dorsal raphe by modulation of extracellular 5-HT levels. Annals of the New York Academy of Sciences. 881: 365-8. PMID 10415938 DOI: 10.1111/j.1749-6632.1999.tb09382.x  0.587
1999 Adell A, Artigas F. Regulation of the release of 5-hydroxytryptamine in the median raphe nucleus of the rat by catecholaminergic afferents. The European Journal of Neuroscience. 11: 2305-11. PMID 10383619 DOI: 10.1046/j.1460-9568.1999.00642.x  0.32
1999 Casanovas JM, Hervás I, Artigas F. Postsynaptic 5-HT1A receptors control 5-HT release in the rat medial prefrontal cortex. Neuroreport. 10: 1441-5. PMID 10380960  0.624
1999 Casanovas JM, Vilaró MT, Mengod G, Artigas F. Differential regulation of somatodendritic serotonin 5-HT1A receptors by 2-week treatments with the selective agonists alnespirone (S-20499) and 8-hydroxy-2-(Di-n-propylamino)tetralin: microdialysis and autoradiographic studies in rat brain. Journal of Neurochemistry. 72: 262-72. PMID 9886078 DOI: 10.1046/j.1471-4159.1999.0720262.x  0.483
1998 Adell A, Artigas F. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat. British Journal of Pharmacology. 125: 1361-7. PMID 9863668 DOI: 10.1038/sj.bjp.0702206  0.57
1998 Hervás I, Artigas F. Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors. European Journal of Pharmacology. 358: 9-18. PMID 9809863 DOI: 10.1016/S0014-2999(98)00579-2  0.56
1998 Hervás I, Bel N, Fernández AG, Palacios JM, Artigas F. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Naunyn-Schmiedeberg's Archives of Pharmacology. 358: 315-22. PMID 9774218 DOI: 10.1007/PL00005259  0.613
1998 Dugast C, Soulière F, Schmitt P, Casanovas JM, Fattaccini CM, Mocaër E, Lesourd M, Renaud B, Artigas F, Hamon M, Chouvet G. Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain? European Journal of Pharmacology. 350: 171-80. PMID 9696405 DOI: 10.1016/S0014-2999(98)00254-4  0.475
1998 Pérez V, Bel N, Celada P, Ortiz J, Alvarez E, Artigas F. Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments. Journal of Clinical Psychopharmacology. 18: 222-30. PMID 9617981  0.469
1998 Romero L, Jernej B, Bel N, Cicin-Sain L, Cortés R, Artigas F. Basal and stimulated extracellular serotonin concentration in the brain of rats with altered serotonin uptake. Synapse (New York, N.Y.). 28: 313-21. PMID 9517840 DOI: 10.1002/(SICI)1098-2396(199804)28:4<313::AID-SYN7>3.0.CO;2-C  0.546
1997 Casanovas JM, Lésourd M, Artigas F. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain. British Journal of Pharmacology. 122: 733-41. PMID 9375971 DOI: 10.1038/sj.bjp.0701420  0.561
1997 Bal N, Figueras G, Vilaró MT, Suñol C, Artigas F. Antidepressant drugs inhibit a glial 5-hydroxytryptamine transporter in rat brain. The European Journal of Neuroscience. 9: 1728-38. PMID 9283827  0.557
1997 Adell A, Casanovas JM, Artigas F. Comparative study in the rat of the actions of different types of stress on the release of 5-HT in raphe nuclei and forebrain areas. Neuropharmacology. 36: 735-41. PMID 9225300 DOI: 10.1016/S0028-3908(97)00048-8  0.611
1997 Pérez V, Gilaberte I, Faries D, Alvarez E, Artigas F. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet (London, England). 349: 1594-7. PMID 9174562 DOI: 10.1016/S0140-6736(96)08007-5  0.357
1997 Romero L, Artigas F. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors. Journal of Neurochemistry. 68: 2593-603. PMID 9166757  0.625
1996 Romero L, Hervás I, Artigas F. The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neuroscience Letters. 219: 123-6. PMID 8971795  0.572
1996 Romero L, Bel N, Casanovas JM, Artigas F. Two actions are better than one: avoiding self-inhibition of serotonergic neurones enhances the effects of serotonin uptake inhibitors. International Clinical Psychopharmacology. 11: 1-8. PMID 8923121  0.604
1996 Gardier AM, Malagié I, Trillat AC, Jacquot C, Artigas F. Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundamental & Clinical Pharmacology. 10: 16-27. PMID 8900496  0.582
1996 Romero L, Bel N, Artigas F, de Montigny C, Blier P. Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 15: 349-60. PMID 8887989 DOI: 10.1016/0893-133X(95)00240-E  0.687
1996 Artigas F, Romero L, de Montigny C, Blier P. Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists. Trends in Neurosciences. 19: 378-83. PMID 8873352 DOI: 10.1016/S0166-2236(96)10037-0  0.647
1996 Casanovas JM, Artigas F. Differential effects of ipsapirone on 5-hydroxytryptamine release in the dorsal and median raphe neuronal pathways. Journal of Neurochemistry. 67: 1945-52. PMID 8863499  0.587
1996 Bel N, Artigas F. In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies. The Journal of Pharmacology and Experimental Therapeutics. 278: 1064-72. PMID 8819487  0.425
1996 Bel N, Artigas F. Reduction of serotonergic function in rat brain by tryptophan depletion: effects in control and fluvoxamine-treated rats. Journal of Neurochemistry. 67: 669-76. PMID 8764594  0.518
1996 Artigas F, Romero L, Pérez V, Alvarez E. Augmentation of antidepressant effects with 5HT-1A antagonists. Basic and clinical studies European Neuropsychopharmacology. 6: 16. DOI: 10.1016/0924-977X(96)87373-1  0.489
1995 Ferré S, Artigas F. Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism. Neuroscience Letters. 187: 61-4. PMID 7617304  0.527
1995 Bel N, Artigas F. In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain. Naunyn-Schmiedeberg's Archives of Pharmacology. 351: 475-82. PMID 7543977  0.484
1995 Artigas F. Pindolol, 5-hydroxytryptamine, and antidepressant augmentation. Archives of General Psychiatry. 52: 969-71. PMID 7487345  0.419
1995 Artigas F. Selective Serotonin/Noradrenaline Reuptake Inhibitors (SNRIs) Cns Drugs. 4: 79-89. DOI: 10.2165/00023210-199504020-00001  0.552
1994 Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Archives of General Psychiatry. 51: 248-51. PMID 8122960 DOI: 10.1001/Archpsyc.1994.03950030084009  0.63
1994 Celada P, Martín F, Artigas F. Effects of chronic treatment with dexfenfluramine on serotonin in rat blood, brain and lung tissue. Life Sciences. 55: 1237-43. PMID 7934621  0.496
1994 Celada P, Bel N, Artigas F. The effects of brofaromine, a reversible MAO-A inhibitor, on extracellular serotonin in the raphe nuclei and frontal cortex of freely moving rats. Journal of Neural Transmission. Supplementum. 41: 357-63. PMID 7931251  0.574
1994 Romero L, Celada P, Artigas F. Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/G(o) proteins in dorsal raphe nucleus. European Journal of Pharmacology. 265: 103-6. PMID 7883021  0.543
1994 Ferré S, Cortés R, Artigas F. Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 4839-46. PMID 7519257  0.557
1993 Artigas F. 5-HT and antidepressants: new views from microdialysis studies. Trends in Pharmacological Sciences. 14: 262. PMID 8212321 DOI: 10.1016/0165-6147(93)90125-4  0.594
1993 Celada P, Artigas F. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat. Naunyn-Schmiedeberg's Archives of Pharmacology. 347: 583-90. PMID 7689703  0.554
1993 Ferré S, Artigas F. Dopamine D2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. Journal of Neurochemistry. 61: 772-5. PMID 7687663  0.554
1993 Adell A, Carceller A, Artigas F. In vivo brain dialysis study of the somatodendritic release of serotonin in the Raphe nuclei of the rat: effects of 8-hydroxy-2-(di-n-propylamino)tetralin. Journal of Neurochemistry. 60: 1673-81. PMID 7682600  0.583
1993 Ortiz J, Mariscot C, Alvarez E, Artigas F. Effects of the antidepressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls. Journal of Affective Disorders. 29: 227-34. PMID 7510316  0.467
1993 Bel N, Artigas F. Chronic treatment with fluvoxamine increases extracellular serotonin in frontal cortex but not in raphe nuclei. Synapse (New York, N.Y.). 15: 243-5. PMID 7506449 DOI: 10.1002/syn.890150310  0.42
1993 Celada P, Artigas F. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues. Journal of Neurochemistry. 61: 2191-8. PMID 7504085  0.367
1992 Ortiz J, Artigas F. Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine. British Journal of Pharmacology. 105: 941-6. PMID 1387022  0.495
1992 Celada P, Dolera M, Alvarez E, Artigas F. Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement. Journal of Affective Disorders. 25: 243-9. PMID 1385505  0.496
1992 Martín F, Artigas F. Simultaneous effects of p-chloroamphetamine, d-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood. Journal of Neurochemistry. 59: 1138-44. PMID 1379630  0.412
1992 Celada P, Pérez J, Alvarez E, Artigas F. Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement. Journal of Clinical Psychopharmacology. 12: 309-15. PMID 1282522  0.485
1992 Bel N, Artigas F. Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study. European Journal of Pharmacology. 229: 101-3. PMID 1282104 DOI: 10.1016/0014-2999(92)90292-C  0.631
1992 Celada P, Artigas F. EFFECTS OF MAO INHIBITORS ON EXTRACELLULAR SEROTONIN IN THE RAPHE NUCLEI AND FRONTAL CORTEX. AN IN VIVO MICRODIALYSIS STUDY IN THE AWAKE RAT. Clinical Neuropharmacology. 15: 431B. DOI: 10.1097/00002826-199202001-00837  0.346
1992 Artigas F, Adell A, Celada P, Bel N. The Raphe nuclei as a preferential target for antidepressant drugs acting on the 5-HT system: in vivo microdialysis studies in freely-moving rats European Neuropsychopharmacology. 2: 276-277. DOI: 10.1016/0924-977X(92)90108-K  0.458
1991 Sarrias MJ, Martínez E, Celada P, Udina C, Alvarez E, Artigas F. Plasma free 5HT and platelet 5HT in depression: case-control studies and the effect of antidepressant therapy. Advances in Experimental Medicine and Biology. 294: 653-8. PMID 1722955  0.463
1991 Adell A, Artigas F. Effects of clomipramine on extracellular serotonin in the rat frontal cortex. Advances in Experimental Medicine and Biology. 294: 451-4. PMID 1722948  0.326
1991 Ortiz J, Celada P, Martínez E, Artigas F. Plasma free 5HT, plasma 5HIAA and whole blood 5HT in the rat. Advances in Experimental Medicine and Biology. 294: 447-50. PMID 1722947  0.437
1991 Ortiz J, Mocaër E, Artigas F. Effects of the antidepressant drug tianeptine on plasma and platelet serotonin concentrations in the rat. European Journal of Pharmacology. 199: 335-9. PMID 1717295  0.457
1991 Adell A, Artigas F. Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study. Naunyn-Schmiedeberg's Archives of Pharmacology. 343: 237-44. PMID 1714040 DOI: 10.1007/BF00251121  0.6
1991 Adell A, Carceller A, Artigas F. Regional distribution of extracellular 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in the brain of freely moving rats. Journal of Neurochemistry. 56: 709-12. PMID 1703223  0.523
1990 Celada P, Sarrias MJ, Artigas F. Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity. Journal of Neural Transmission. Supplementum. 32: 149-54. PMID 1708403  0.469
1990 Sarrias MJ, Cabré P, Martínez E, Artigas F. Relationship between serotoninergic measures in blood and cerebrospinal fluid simultaneously obtained in humans. Journal of Neurochemistry. 54: 783-6. PMID 1689378  0.443
1989 Artigas F, Sarrias MJ, Martínez E, Gelpí E, Alvarez E, Udina C. Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium. Psychopharmacology. 99: 328-32. PMID 2480614  0.499
1989 Sarrias MJ, Artigas F, Martínez E, Gelpí E. Seasonal changes of plasma serotonin and related parameters: correlation with environmental measures. Biological Psychiatry. 26: 695-706. PMID 2478199  0.435
1988 Ortiz J, Artigas F, Gelpí E. Serotonergic status in human blood. Life Sciences. 43: 983-90. PMID 2459577  0.478
1988 Artigas F, Martínez E, Camón L, Rodríguez Farré E. Synthesis and utilization of neurotransmitters: actions of subconvulsant doses of hexachlorocyclohexane isomers on brain monoamines. Toxicology. 49: 49-55. PMID 2453940  0.351
1987 Sarrias MJ, Artigas F, Martínez E, Gelpí E, Alvarez E, Udina C, Casas M. Decreased plasma serotonin in melancholic patients: a study with clomipramine. Biological Psychiatry. 22: 1429-38. PMID 3676370  0.457
1985 Artigas F, Sarrias MJ, Martínez E, Gelpí E. Serotonin in body fluids: characterization of human plasmatic and cerebrospinal fluid pools by means of a new HPLC method. Life Sciences. 37: 441-7. PMID 3160903  0.462
1985 Artigas F, Suñol C, Tusell JM, Martínez E, Gelpí E. Comparative ontogenesis of brain tryptamine, serotonin, and tryptophan. Journal of Neurochemistry. 44: 31-7. PMID 2578059  0.324
1983 Große W, Artigas F. Incorporation of 15N-Ammonia into Serotonin in Cotyledons of Maturing Walnuts Zeitschrift FüR Naturforschung C. 38: 1057-1058. DOI: 10.1515/znc-1983-11-1228  0.475
Low-probability matches (unlikely to be authored by this person)
2007 Lladó L, Artigas F, Celada P. P.1.34 Involvement of GABAergic interneurons on the modulation of pyramidal neuron activity in PFC by 8-OH-DPAT European Neuropsychopharmacology. 17: S30-S31. DOI: 10.1016/S0924-977X(07)70035-4  0.296
1995 Artigas F, Romero L, Bel N, Pérez V, Alvarez E. S-11-5 Enhanced antidepressant responses with antagonists of somatodendritic 5-HT1A receptors. Basic and clinical studies European Neuropsychopharmacology. 5: 191. DOI: 10.1016/0924-977X(95)90202-O  0.295
2015 Lladó-Pelfort L, Troyano-Rodriguez E, van den Munkhof HE, Cervera-Ferri A, Jurado N, Núñez-Calvet M, Artigas F, Celada P. Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: Effects of antipsychotic drugs and receptor ligands European Neuropsychopharmacology. DOI: 10.1016/j.euroneuro.2015.11.015  0.291
2009 Lladó-Pelfort L, Artigas F, Celada P. P.3.d.018 GABAergic intemeurons are involved in the excitatory action of 8-OH-DPAT on prefrontal cortex pyramidal neurons European Neuropsychopharmacology. 19: S564. DOI: 10.1016/S0924-977X(09)70900-9  0.291
2017 Alarcón-Arís D, Recasens A, Galofré M, Carballo-Carbajal I, Zacchi N, Ruiz-Bronchal E, Pavia-Collado R, Chica R, Ferrés-Coy A, Santos M, Revilla R, Montefeltro A, Fariñas I, Artigas F, Vila M, et al. Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 29273501 DOI: 10.1016/j.ymthe.2017.11.015  0.29
2015 Castañé A, Kargieman L, Celada P, Bortolozzi A, Artigas F. 5-HT2A receptors are involved in cognitive but not antidepressant effects of fluoxetine European Neuropsychopharmacology. 25: 1353-1361. DOI: 10.1016/j.euroneuro.2015.04.006  0.282
2005 Díaz-Mataix L, Celada P, Artigas F. P.1.20 Activation of pyramidal cells in rat medial prefrontal cortex projecting to ventral tegmental area by exogenous 5-HT1A receptor activation European Neuropsychopharmacology. 15: S17-S18. DOI: 10.1016/S0924-977X(05)80125-7  0.282
2003 Serrats J, Artigas F, Mengod G, Cortés R. GABAB receptor mRNA in the raphe nuclei: co-expression with serotonin transporter and glutamic acid decarboxylase. Journal of Neurochemistry. 84: 743-52. PMID 12562519 DOI: 10.1046/J.1471-4159.2003.01557.X  0.282
2012 Masana M, Santana N, Artigas F, Bortolozzi A. Dopamine neurotransmission and atypical antipsychotics in prefrontal cortex: a critical review. Current Topics in Medicinal Chemistry. 12: 2357-74. PMID 23279176  0.277
2014 Troyano-Rodriguez E, Lladó-Pelfort L, Santana N, Teruel-Martí V, Celada P, Artigas F. Phencyclidine inhibits the activity of thalamic reticular gamma-aminobutyric acidergic neurons in rat brain. Biological Psychiatry. 76: 937-45. PMID 25038984 DOI: 10.1016/j.biopsych.2014.05.019  0.271
2013 Hensler JG, Artigas F, Bortolozzi A, Daws LC, De Deurwaerdère P, Milan L, Navailles S, Koek W. Catecholamine/Serotonin interactions: systems thinking for brain function and disease. Advances in Pharmacology (San Diego, Calif.). 68: 167-97. PMID 24054145 DOI: 10.1016/B978-0-12-411512-5.00009-9  0.271
2008 Kargieman L, Santana N, Mengod G, Celada P, Artigas F. NMDA antagonist and antipsychotic actions in cortico-subcortical circuits. Neurotoxicity Research. 14: 129-40. PMID 19073421 DOI: 10.1007/BF03033805  0.27
2019 Fullana MN, Covelo A, Bortolozzi A, Araque A, Artigas F. In vivo knockdown of astroglial glutamate transporters GLT-1 and GLAST increases excitatory neurotransmission in mouse infralimbic cortex: Relevance for depressive-like phenotypes. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 31582286 DOI: 10.1016/J.Euroneuro.2019.09.004  0.263
2023 Riga MS, Paz V, Didriksen M, Celada P, Artigas F. Lu AF35700 reverses the phencyclidine-induced disruption of thalamo-cortical activity by blocking dopamine D and D receptors. European Journal of Pharmacology. 175802. PMID 37295763 DOI: 10.1016/j.ejphar.2023.175802  0.26
1995 Casanovas J, Artigas F. P-11-14 Effects of the selective 5-HT1A agonist alnespirone on in vivo 5-hydroxytryptamine release European Neuropsychopharmacology. 5: 408. DOI: 10.1016/0924-977X(95)90766-7  0.26
2016 Gasull-Camós J, Artigas F, Castañé A. Boosting glutamatergic neurotransmission in infralimbic − but not prelimbic − cortex evokes antidepressant-like responses in rats through AMPA receptor activation European Neuropsychopharmacology. 26: S243-S244. DOI: 10.1016/S0924-977X(16)31111-7  0.256
2011 Masana M, Bortolozzi A, Artigas F. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 14: 53-68. PMID 20701825 DOI: 10.1017/S1461145710000908  0.255
2015 Ferrés-Coy A, Galofré M, Pilar-Cuéllar F, Vidal R, Paz V, Ruiz-Bronchal E, Campa L, Pazos, Caso JR, Leza JC, Alvarado G, Montefeltro A, Valdizán EM, Artigas F, Bortolozzi A. Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration Molecular Psychiatry. DOI: 10.1038/mp.2015.80  0.254
2016 Foraster MA, Celada P, Jensen A, Plath N, Herrik K, Artigas F. P.2.010 Ketamine inhibits the activity of thalamic neurons in anesthetized rats European Neuropsychopharmacology. 26: S31-S32. DOI: 10.1016/S0924-977X(16)70036-8  0.254
2008 Scorza MC, Meikle MN, Hill XL, Richeri A, Lorenzo D, Artigas F. Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapine. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 11: 519-32. PMID 18248688 DOI: 10.1017/S1461145708008432  0.253
2002 Artigas F, Nutt DJ, Shelton R. Mechanism of action of antidepressants. Psychopharmacology Bulletin. 36: 123-32. PMID 12490828  0.249
2003 Amargós-Bosch M, Adell A, Bortolozzi A, Artigas F. Stimulation of α1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: Reversal by antipsychotic drugs Journal of Neurochemistry. 87: 831-842. DOI: 10.1046/j.1471-4159.2003.02044.x  0.245
2015 Gasull-Camós J, Artigas F, Castañé A. S.12.03 Modulation of glutamatergic transmission in the infralimbic cortex evokes antidepressant-like effects in rats European Neuropsychopharmacology. 25: S127-S128. DOI: 10.1016/S0924-977X(15)30063-8  0.244
2015 Riga M, Celada P, Sanchez C, Artigas F. P.2.e.004 Sub-chronic vortioxetine treatment – but not escitalopram – enhances pyramidal neuron activity in the rat prefrontal cortex European Neuropsychopharmacology. 25: S433. DOI: 10.1016/S0924-977X(15)30579-4  0.241
2013 Troyano-Rodríguez E, Santana N, Lladó-Pelfort L, Celada P, Artigas F. P.3.a.004 Phencyclidine activates thalamocortical networks by inhibiting GABAergic neurons in the reticular nucleus of the thalamus European Neuropsychopharmacology. 23: S423-S424. DOI: 10.1016/S0924-977X(13)70670-9  0.24
1992 CORTES R, ORTIZ J, MENGOD G, ARTIGAS F. EFFECT OF ANTIDEPRESSANT DRUGS ON THE SEROTONERGIC SYSTEM Behavioural Pharmacology. 3: 34. DOI: 10.1097/00008877-199204001-00100  0.23
1992 CELADA P, ADELL A, ARTIGAS F. EFFECTS OF ANTIDEPRESSANT DRUGS ON THE SEROTONERGIC SYSTEM Behavioural Pharmacology. 3: 33. DOI: 10.1097/00008877-199204001-00098  0.23
2022 Tarrés-Gatius M, López-Hill X, Miquel-Rio L, Castarlenas L, Fabius S, Santana N, Vilaró MT, Artigas F, Scorza MC, Castañé A. Discrimination of motor and sensorimotor effects of phencyclidine and MK-801: Involvement of GluN2C-containing NMDA receptors in psychosis-like models. Neuropharmacology. 213: 109079. PMID 35561792 DOI: 10.1016/j.neuropharm.2022.109079  0.227
2013 Artigas F. PL.01.01 Prefrontal cortex-based circuits: relevance for antidepressant and antipsychotic drug action European Neuropsychopharmacology. 23: S107. DOI: 10.1016/S0924-977X(13)00242-3  0.223
2022 Fullana MN, Paz V, Artigas F, Bortolozzi A. Ketamine triggers rapid antidepressant effects by modulating synaptic plasticity in a new depressive-like mouse model based on astrocyte glutamate transporter GLT-1 knockdown in infralimbic cortex. Revista De Psiquiatria Y Salud Mental. 15: 94-100. PMID 35840289 DOI: 10.1016/j.rpsmen.2022.06.008  0.22
1993 Cortés R, Mengod G, Celada P, Artigas F. p-chlorophenylalanine increases tryptophan-5-hydroxylase mRNA levels in the rat dorsal raphe: a time course study using in situ hybridization. Journal of Neurochemistry. 60: 761-4. PMID 8419551  0.22
2020 Tarrés-Gatius M, Miquel-Rio L, Campa L, Artigas F, Castañé A. Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine. Translational Psychiatry. 10: 427. PMID 33303736 DOI: 10.1038/s41398-020-01110-y  0.218
2014 Artigas F. Deep brain stimulation in major depression: plastic changes of 5-hydroxytryptamine neurons. Biological Psychiatry. 76: 174-5. PMID 25012045 DOI: 10.1016/j.biopsych.2014.05.008  0.217
2014 Gomez-Sintes R, Bortolozzi A, Artigas F, Lucas JJ. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1524-33. PMID 25088904 DOI: 10.1016/j.euroneuro.2014.07.004  0.217
2005 Pineda JR, Canals JM, Bosch M, Adell A, Mengod G, Artigas F, Ernfors P, Alberch J. Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease. Journal of Neurochemistry. 93: 1057-68. PMID 15934928 DOI: 10.1111/J.1471-4159.2005.03047.X  0.211
1994 Ferrer A, Artigas F. Effects of single and chronic treatment with tranylcypromine on extracellular serotonin in rat brain. European Journal of Pharmacology. 263: 227-34. PMID 7531152  0.208
2020 Cathala A, Devroye C, Robert É, Vallée M, Revest JM, Artigas F, Spampinato U. Serotonin2B receptor blockade in the rat dorsal raphe nucleus suppresses cocaine-induced hyperlocomotion through an opposite control of mesocortical and mesoaccumbens dopamine pathways. Neuropharmacology. 180: 108309. PMID 32956675 DOI: 10.1016/J.Neuropharm.2020.108309  0.208
1999 Pérez V, Soler J, Puigdemont D, Alvarez E, Artigas F. A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius. Archives of General Psychiatry. 56: 375-9. PMID 10197835 DOI: 10.1001/ARCHPSYC.56.4.375  0.207
2011 Artigas F. [Glutamatergic antidepressants? The intriguing antidepressant properties of ketamine]. Revista De Psiquiatrí́a Y Salud Mental. 4: 183-6. PMID 23446263 DOI: 10.1016/j.rpsm.2011.07.002  0.203
2012 Bortolozzi A, Castañé A, Semakova J, Santana N, Alvarado G, Cortés R, Ferrés-Coy A, Fernández G, Carmona MC, Toth M, Perales JC, Montefeltro A, Artigas F. New antidepressant strategy based on acute siRNA silencing of 5-HT1A autoreceptors. Molecular Psychiatry. 17: 567. PMID 22617870 DOI: 10.1038/mp.2012.52  0.201
2001 Pérez V, Puiigdemont D, Gilaberte I, Alvarez E, Artigas F. Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors. Journal of Clinical Psychopharmacology. 21: 36-45. PMID 11199945 DOI: 10.1097/00004714-200102000-00008  0.197
2008 Lladó-Pelfort L, Assié M, Celada P, Newman-Tancredi A, Artigas F. P.1.c.047 F15599, a post-synaptic cortical preferential 5-HT1A agonist: III) electrophysiology and microdialysis European Neuropsychopharmacology. 18: S246. DOI: 10.1016/S0924-977X(08)70311-0  0.192
2007 Gómez-Sintes R, Hernández F, Bortolozzi A, Artigas F, Avila J, Zaratin P, Gotteland JP, Lucas JJ. Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice. The Embo Journal. 26: 2743-54. PMID 17510631 DOI: 10.1038/sj.emboj.7601725  0.191
2016 Llinàs MF, Bortolozzi A, Artigas F. P.4.014 siRNA-mediated suppression of astroglial glutamate transporters in infralimbic cortex induces depressive-like behaviours European Neuropsychopharmacology. 26: S97. DOI: 10.1016/S0924-977X(16)70104-0  0.184
1997 Zanardi R, Artigas F, Franchini L, Sforzini L, Gasperini M, Smeraldi E, Perez J. How long should pindolol be associated with paroxetine to improve the antidepressant response? Journal of Clinical Psychopharmacology. 17: 446-50. PMID 9408806  0.183
2016 Foraster MA, Celada P, Jensen A, Plath N, Herrik K, Artigas F. Ketamine modulates the activity of thalamo-cortical networks in anesthetized rats European Neuropsychopharmacology. 26: S136-S137. DOI: 10.1016/S0924-977X(16)30927-0  0.18
1996 Artigas F, Bel N, Casanovas JM, Romero L. Adaptative changes of the serotonergic system after antidepressant treatments. Advances in Experimental Medicine and Biology. 398: 51-9. PMID 8906240  0.18
2007 Martinez de Lagran M, Bortolozzi A, Millan O, Gispert JD, Gonzalez JR, Arbones ML, Artigas F, Dierssen M. Dopaminergic deficiency in mice with reduced levels of the dual-specificity tyrosine-phosphorylated and regulated kinase 1A, Dyrk1A(+/-). Genes, Brain, and Behavior. 6: 569-78. PMID 17137466 DOI: 10.1111/J.1601-183X.2006.00285.X  0.18
1990 Artigas F, Martínez E, Adell A. Non-specific inhibition of imipramine binding argues against an endogenous ligand. European Journal of Pharmacology. 181: 9-15. PMID 2387322  0.179
2020 Fernández-García S, Conde-Berriozabal S, García-García E, Gort-Paniello C, Bernal-Casas D, García-Díaz Barriga G, López-Gil J, Muñoz-Moreno E, Soria G, Campa L, Artigas F, Rodríguez MJ, Alberch J, Masana M. M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington's disease. Elife. 9. PMID 33016873 DOI: 10.7554/eLife.57017  0.178
2016 Fullana Llinàs M, Ferrés-Coy A, Ruiz-Bronchal E, Bortolozzi A, Artigas F. Selective siRNA-mediated suppression of astroglial glutamate transporters in infralimbic cortex induces depressive-like behaviors in mice European Neuropsychopharmacology. 26: S454. DOI: 10.1016/S0924-977X(16)31444-4  0.176
2009 Portella MJ, de Diego-Adeliño J, Puigdemont D, Pérez-Egea R, Alvarez E, Artigas F, Pérez V. Pindolol augmentation enhances response outcomes in first depressive episodes. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 516-9. PMID 19419845 DOI: 10.1016/j.euroneuro.2009.04.004  0.173
2011 Portella MJ, de Diego-Adeliño J, Ballesteros J, Puigdemont D, Oller S, Santos B, Álvarez E, Artigas F, Pérez V. Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression. The Journal of Clinical Psychiatry. 72: 962-9. PMID 21034693 DOI: 10.4088/JCP.09m05827blu  0.172
2021 Artigas F. Brain circuitry in major depressive disorder: The critical role of ventral anterior cingulate cortex. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 51: 134-137. PMID 34391028 DOI: 10.1016/j.euroneuro.2021.07.001  0.17
2023 Tristán-Noguero A, Fernández-Carasa I, Calatayud C, Bermejo-Casadesús C, Pons-Espinal M, Colini Baldeschi A, Campa L, Artigas F, Bortolozzi A, Domingo-Jiménez R, Ibáñez S, Pineda M, Artuch R, Raya Á, García-Cazorla À, et al. iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation. Embo Molecular Medicine. e15847. PMID 36740977 DOI: 10.15252/emmm.202215847  0.169
1994 Ferré S, Giménez-Llort L, Artigas F, Martínez E. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors. European Journal of Pharmacology. 255: 203-13. PMID 7913043  0.168
2001 Artigas F. Control of serotonergic activity by amino acid transmission. Implications for antidepressant treatments European Neuropsychopharmacology. 11: S117-S118. DOI: 10.1016/S0924-977X(01)80035-3  0.168
2015 Udina M, Navinés R, Egmond E, Oriolo G, Langorh K, Gimenez D, Valdés M, Gómez-Gil E, Grande I, Gratacós M, Kapczinski F, Artigas F, Vieta E, Solà R, Martín-Santos R. Glucocorticoid receptors, brain-derived neurotrophic factor, serotonin and dopamine neurotransmission are associated with interferon-induced depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26721949 DOI: 10.1093/Ijnp/Pyv135  0.167
2016 Aris DA, Artigas F, Bortolozzi A. P.1.014 Early changes induced by α-synuclein in monoamine neurons: new therapeutic strategies for Parkinson's disease European Neuropsychopharmacology. 26: S14. DOI: 10.1016/S0924-977X(16)70016-2  0.165
2014 Lladó-Pelfort L, Artigas F, Castañé A. P.2.027 Modeling EEG endophenotypes in a murine NMDA receptor antagonist model of schizophrenia European Neuropsychopharmacology. 24: S51-S52. DOI: 10.1016/S0924-977X(14)70058-6  0.165
2008 Santana N, Celada P, Mengod G, Artigas F. P.1.b.004 Activation of thalamo-cortical circuits by phencyclidine, reversal by clozapine European Neuropsychopharmacology. 18: S218-S219. DOI: 10.1016/S0924-977X(08)70262-1  0.164
2002 Miró X, Pérez-Torres S, Artigas F, Puigdomènech P, Palacios JM, Mengod G. Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology. 43: 1148-57. PMID 12504921 DOI: 10.1016/S0028-3908(02)00220-4  0.162
1991 Martínez E, de Vera N, Artigas F. Differential response of rat brain polyamines to convulsant agents. Life Sciences. 48: 77-84. PMID 1702501  0.16
1995 Artigas F, Bel N. P-2-13 Acute and chronic effects of imipramine on serotonergic function. Microdialysis studies in conscious rats European Neuropsychopharmacology. 5: 278. DOI: 10.1016/0924-977X(95)90378-Q  0.159
2016 Van den Munkhof H, Celada P, Artigas F. P.2.020 The novel antipsychotic brexpiprazole partly reverses a disruption of thalamocortical function induced by phencyclidine European Neuropsychopharmacology. 26: S40-S41. DOI: 10.1016/S0924-977X(16)70046-0  0.154
2008 Artigas F. C.19.01 Non serotonergic circuits involved in depression European Neuropsychopharmacology. 18: S609. DOI: 10.1016/S0924-977X(08)70958-1  0.152
1979 Artigas F, Gelpí E. A new mass fragmentographic method for the simultaneous analysis of tryptophan, tryptamine, indole-3-acetic acid, serotonin, and 5-hydroxyindole-3-acetic acid in the same sample of rat brain. Analytical Biochemistry. 92: 233-42. PMID 426283  0.15
2013 Spedding M, Schenker E, Godsil B, Jay T, Sebban C, Takillah S, Faure P, Siok C, Hajos M, Bastlund J, Wicke K, Artigas F. S.03.01 Alterations of the hippocampal-prefrontal pathway in schizophrenia: effect of antipsychotic drugs European Neuropsychopharmacology. 23: S114. DOI: 10.1016/S0924-977X(13)70130-5  0.149
1996 Pérez V, Gilaberte I, Faries D, Alvarez E, Artigas F. Pindolol augments the antidepressant efficacy of fluoxetine. Results of a double-blind, controlled trial European Neuropsychopharmacology. 6: S4-88-S4-89. DOI: 10.1016/0924-977X(96)83241-X  0.147
1989 Artigas F. Brain 5-HT1A Receptors. Edited by C. T. Dourish, S. Ahlenius, and P. H. Hutson. Published jointly by Ellis Horwood, Chichester, England and VCH Verlagsgesellchaft, Weinheim, FRG. 1987. 306pp. 17 × 24.5cm. ISBN 0‐89573‐575‐x. $85.00. Journal of Pharmaceutical Sciences. 78: 351. DOI: 10.1002/jps.2600780419  0.143
2021 Pavia-Collado R, Cóppola-Segovia V, Miquel-Rio L, Alarcón-Aris D, Rodríguez-Aller R, Torres-López M, Paz V, Ruiz-Bronchal E, Campa L, Artigas F, Montefeltro A, Revilla R, Bortolozzi A. Intracerebral Administration of a Ligand-ASO Conjugate Selectively Reduces α-Synuclein Accumulation in Monoamine Neurons of Double Mutant Human A30P*A53T*α-Synuclein Transgenic Mice. International Journal of Molecular Sciences. 22. PMID 33805843 DOI: 10.3390/ijms22062939  0.142
1992 de Vera N, Serratosa J, Artigas F, Martínez E. Toxic effects of putrescine in rat brain: Polyamines can be involved in the action of excitotoxins. Amino Acids. 3: 261-9. PMID 24193126 DOI: 10.1007/BF00806001  0.142
2024 Toker D, Müller E, Miyamoto H, Riga MS, Lladó-Pelfort L, Yamakawa K, Artigas F, Shine JM, Hudson AE, Pouratian N, Monti MM. Criticality supports cross-frequency cortical-thalamic information transfer during conscious states. Elife. 13. PMID 38180472 DOI: 10.7554/eLife.86547  0.138
2013 Riga M, Artigas F, Celada P. P.2.017 The hallucinogen 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) disrupts cortical function: reversal by antipsychotic drugs European Neuropsychopharmacology. 23: S40-S41. DOI: 10.1016/S0924-977X(13)70045-2  0.137
2015 Puigdemont D, Portella M, Pérez-Egea R, Molet J, Gironell A, de Diego-Adeliño J, Martín A, Rodríguez R, Àlvarez E, Artigas F, Pérez V. A randomized double-blind crossover trial of deep brain stimulation of the subcallosal cingulate gyrus in patients with treatment-resistant depression: a pilot study of relapse prevention. Journal of Psychiatry & Neuroscience : Jpn. 40: 224-31. PMID 25652752 DOI: 10.1503/jpn.130295  0.13
2014 Lladó-Pelfort L, Celada P, Artigas F. P.1.a.010 Brain oscillatory patterns in 22q11 transgenic mice model. Interaction with non-competitive NMDA receptor antagonists European Neuropsychopharmacology. 24: S158-S159. DOI: 10.1016/S0924-977X(14)70241-X  0.129
2000 Sacristán JA, Gilaberte I, Boto B, Buesching DP, Obenchain RL, Demitrack M, Pérez Sola V, Alvarez E, Artigas F. Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial. International Clinical Psychopharmacology. 15: 107-13. PMID 10759342 DOI: 10.1097/00004850-200015020-00007  0.129
2021 Bortolozzi A, Manashirov S, Chen A, Artigas F. Oligonucleotides as therapeutic tools for brain disorders: Focus on major depressive disorder and Parkinson's disease. Pharmacology & Therapeutics. 107873. PMID 33915178 DOI: 10.1016/j.pharmthera.2021.107873  0.129
2020 Alarcón-Arís D, Pavia-Collado R, Miquel-Rio L, Coppola-Segovia V, Ferrés-Coy A, Ruiz-Bronchal E, Galofré M, Paz V, Campa L, Revilla R, Montefeltro A, Kordower JH, Vila M, Artigas F, Bortolozzi A. Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys. Ebiomedicine. 59: 102944. PMID 32810825 DOI: 10.1016/J.Ebiom.2020.102944  0.128
1986 Parra P, Martinez E, Suñol C, Artigas F, Tusell J, Gelpl E, Albaigés J. Analysis, accumulation and central effects of trihalomethanes. I. bromoform† Toxicological & Environmental Chemistry. 11: 79-91. DOI: 10.1080/02772248609357122  0.126
1991 de Vera N, Artigas F, Serratosa J, Martínez E. Changes in polyamine levels in rat brain after systemic kainic acid administration: relationship to convulsant activity and brain damage. Journal of Neurochemistry. 57: 1-8. PMID 2051159  0.122
2021 Alarcón-Arís D, Pavia-Collado R, Miquel-Rio L, Coppola-Segovia V, Ferrés-Coy A, Ruiz-Bronchal E, Galofré M, Paz V, Campa L, Revilla R, Montefeltro A, Kordower JH, Vila M, Artigas F, Bortolozzi A. Corrigendum to "Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeys" [EBioMedicine 2020; 59:102944]. Ebiomedicine. 74: 103731. PMID 34852293 DOI: 10.1016/j.ebiom.2021.103731  0.121
1999 Artigas F, Pérez V, Alvarez E, Hervás I, Queiroz C, Adell A, Raurich A, Cortés R. Neurobiological differences between responders and non-responders to SSRI treatments. Evidence from pindolol augmentation European Neuropsychopharmacology. 9: 177-178. DOI: 10.1016/S0924-977X(99)80070-4  0.118
2012 Puigdemont D, Pérez-Egea R, Portella MJ, Molet J, de Diego-Adeliño J, Gironell A, Radua J, Gómez-Anson B, Rodríguez R, Serra M, de Quintana C, Artigas F, Álvarez E, Pérez V. Deep brain stimulation of the subcallosal cingulate gyrus: further evidence in treatment-resistant major depression. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 121-33. PMID 21777510 DOI: 10.1017/S1461145711001088  0.118
2015 Castañé A, Santana N, Artigas F. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments. Psychopharmacology. 232: 4085-97. PMID 25943167 DOI: 10.1007/s00213-015-3946-6  0.115
1997 Cañas N, Sanchis D, Gómez G, Casanovas JM, Artigas F, Fernández-López JA, Remesar X, Alemany X. 3-Hydroxybutyrate co-infused with noradrenaline decreases resulting plasma levels of noradrenaline in Wistar rats. The Journal of Experimental Biology. 200: 2641-6. PMID 9359370  0.113
2001 Artigas F, Celada P, Adell A. Sympathomimetic effects of pindolol in depression [1] (multiple letters) Trends in Pharmacological Sciences. 22: 554-555. PMID 11698094  0.113
1994 Mengod G, Artigas F. Meeting Highlights: The 23rd Annual Meeting of the Society for Neuroscience 7-12 November 1993, Washington DC, USA: Unravelling the serotonergic system: from molecular biology to pharmacology Expert Opinion On Investigational Drugs. 3: 393-396. DOI: 10.1517/13543784.3.4.393  0.112
2001 Artigas F, Celada P, Adell A. Sympathomimetic effects of pindolol in depression Trends in Pharmacological Sciences. 22: 554-555. DOI: 10.1016/S0165-6147(00)01828-9  0.111
2006 Artigas F. Review: An early sustained response can occur in the first and second weeks of antidepressant treatment for major depressive disorder - Commentary Evidence-Based Mental Health. 9: 78. DOI: 10.1136/ebmh.9.3.78  0.11
2018 Pavia-Collado R, Alarcón-Arís D, Ruiz-Bronchal E, Artigas F, Bortolozzi A. Impairment of learning and memory in mice overexpressing α- and γ-synuclein in dopaminergic neurons- implication in Parkinson’s disease European Neuropsychopharmacology. 28: S36. DOI: 10.1016/j.euroneuro.2017.12.062  0.109
2013 Artigas F. New strategies in the treatment of major depression Clinical Therapeutics. 35: e111-e112. DOI: 10.1016/J.CLINTHERA.2013.07.342  0.109
2006 Artigas F. Review: an early sustained response can occur in the first and second weeks of antidepressant treatment for major depressive disorder. Evidence-Based Mental Health. 9: 78. PMID 16868197  0.109
2009 Artigas F, Dragheim M, Loft H, Perez V, Álvarez E. P.2.c.040 A randomised, double-blind, placebo-controlled, active-referenced study of Lu AA21004 in patients with major depression European Neuropsychopharmacology. 19: S426-S427. DOI: 10.1016/S0924-977X(09)70661-3  0.108
2016 Artigas F, Schenker E, Celada P, Spedding M, Lladó-Pelfort L, Jurado N, Núñez M, Santana N, Troyano-Rodriguez E, Riga MS, van den Munkhof H, Castañé A, Shaban H, Jay TM, Tripathi A, et al. Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS. Nature Reviews. Drug Discovery. PMID 27811930 DOI: 10.1038/Nrd.2016.205  0.107
2000 Artigas F. New data on augmentation strategies in depression European Neuropsychopharmacology. 10: 203-204. DOI: 10.1016/S0924-977X(00)80115-7  0.106
2016 Didriksen M, Fejgin K, Nilsson SR, Birknow MR, Grayton HM, Larsen PH, Lauridsen JB, Nielsen V, Celada P, Santana N, Kallunki P, Christensen KV, Werge TM, Stensbøl TB, Egebjerg J, ... ... Artigas F, et al. Persistent gating deficit and increased sensitivity to NMDA receptor antagonism after puberty in a new mouse model of the human 22q11.2 microdeletion syndrome: a study in male mice. Journal of Psychiatry & Neuroscience : Jpn. 41: 150381. PMID 27391101 DOI: 10.1503/jpn.150381  0.104
2016 Nilsson SR, Celada P, Fejgin K, Thelin J, Nielsen J, Santana N, Heath CJ, Larsen PH, Nielsen V, Kent BA, Saksida LM, Stensbøl TB, Robbins TW, Bastlund JF, Bussey TJ, ... Artigas F, et al. A mouse model of the 15q13.3 microdeletion syndrome shows prefrontal neurophysiological dysfunctions and attentional impairment. Psychopharmacology. PMID 26983414 DOI: 10.1007/S00213-016-4265-2  0.104
2007 Oller S, Portella M, Puigdemont D, Pérez V, Alvarez E, Artigas F. P.2.c.018 Does pindolol reduce latency of action of SSRI administered intravenously? European Neuropsychopharmacology. 17: S350-S351. DOI: 10.1016/S0924-977X(07)70510-2  0.102
1988 Sanfeliu C, Camón L, Martínez E, Solà C, Artigas F, Rodríguez-Farré E. Regional distribution of lindane in rat brain. Toxicology. 49: 189-96. PMID 2453938  0.101
2017 Artigas F, Bortolozzi A. Therapeutic Potential of Conjugated siRNAs for the Treatment of Major Depressive Disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 42: 371. PMID 27909316 DOI: 10.1038/npp.2016.182  0.1
1996 Manzo L, Artigas F, Martínez E, Mutti A, Bergamaschi E, Nicotera P, Tonini M, Candura SM, Ray DE, Costa LG. Biochemical markers of neurotoxicity. A review of mechanistic studies and applications. Human & Experimental Toxicology. 15: S20-35. PMID 8882557  0.097
2011 Portella MJ, Ballesteros J, Artigas F, Pérez V. Dr Portella and Colleagues reply Journal of Clinical Psychiatry. 72: 1558. DOI: 10.4088/JCP.11lr07366a  0.096
2006 Artigas F, Adell A. Chapter 6.3 The use of brain microdialysis in antidepressant drug research Handbook of Behavioral Neuroscience. 16: 527-543. DOI: 10.1016/S1569-7339(06)16028-2  0.095
2015 Artigas F. PL.02.01 Can we improve speed and efficacy of antidepressant treatments? European Neuropsychopharmacology. 25: S107. DOI: 10.1016/S0924-977X(15)30015-8  0.094
1986 Artigas F, Sarrias MJ, Adell A, Gelpí E. Quantitation of total MHPG in the rat brain using a non enzymatic hydrolysis procedure. Effects of drugs. Life Sciences. 39: 1571-8. PMID 3762318  0.094
2009 Canals I, Carmona MC, Amigó M, Barbera A, Bortolozzi A, Artigas F, Gomis R. A functional leptin system is essential for sodium tungstate antiobesity action. Endocrinology. 150: 642-50. PMID 18845634 DOI: 10.1210/en.2008-0881  0.09
1994 O'Neill MF, Palacios JM, Artigas F. Antidepressant pharmacotherapy: An update on Current clinical and neurochemical perspectives Expert Opinion On Investigational Drugs. 3: 25-34. DOI: 10.1517/13543784.3.1.25  0.089
2007 Toirac I, Sanjuán J, Aguilar EJ, González JC, Artigas F, Rivero O, Nájera C, Moltó MD, de Frutos R. Association between CCK-AR gene and schizophrenia with auditory hallucinations. Psychiatric Genetics. 17: 47-53. PMID 17413443 DOI: 10.1097/YPG.0b013e3280298292  0.088
2013 Artigas F. C.17.01 Cognitive dysfunction in major depression: circuits & targets European Neuropsychopharmacology. 23: S637. DOI: 10.1016/S0924-977X(13)71017-4  0.081
2007 Masana M, Artigas F, Bortolozzi A. P.1.35 Differential regulation of extracellular dopamine between mesocortical and mesolimbic pathways European Neuropsychopharmacology. 17: S31. DOI: 10.1016/S0924-977X(07)70036-6  0.081
2015 Castañé A, Santana N, Artigas F. PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments Psychopharmacology. DOI: 10.1007/s00213-015-3946-6  0.079
1988 Camón L, Martínez E, Artigas F, Solà C, Rodríguez-Farré E. The effect of non-convulsant doses of lindane on temperature and body weight. Toxicology. 49: 389-94. PMID 2453946  0.074
2013 Lladó-Pelfort L, Troyano-Rodríguez E, Jurado N, Artigas F, Celada P. P.3.c.002 Disruption of low frequency oscillations by phencyclidine: mechanisms involved in antipsychotic reversal European Neuropsychopharmacology. 23: S454. DOI: 10.1016/S0924-977X(13)70718-1  0.067
1997 Artigas F. S.11.03 Potential rapid onset: Mechanisms of action European Neuropsychopharmacology. 7: S100-S101. DOI: 10.1016/S0924-977X(97)88394-0  0.067
2005 Artigas F. S.2.1 Behavioral correlates of neurotransmitterfunction in depression European Neuropsychopharmacology. 15: S29-S30. DOI: 10.1016/S0924-977X(05)80139-7  0.066
1987 Artigas F, Gelpí E. Evaluation of the potential of thermospray liquid chromatography-mass spectrometry in neurochemistry. Journal of Chromatography. 394: 123-34. PMID 3597614  0.065
1986 Artigas F, Ortiz J, Sarrias MJ, Martinez E, Gelpí E. Free 5-hydroxytryptamine in plasma: fact or artifact? Clinical Chemistry. 32: 1985-6. PMID 3757235  0.06
2013 Castañé A, Lladó-Pelfort L, Santana N, Artigas F. A.7 - NEUROBIOLOGICAL BASES OF ACUTE AND REPEATED PCP-BASED MICE MODELS OF SCHIZOPHRENIA Behavioural Pharmacology. 24: e24. DOI: 10.1097/01.fbp.0000434768.75496.19  0.059
2007 Ballesteros J, Perez V, Puigdemont D, Callado L, Alvarez E, Artigas F. PMH46 THE SENSITIVITYTO CHANGE OF THE HAMILTON (HAMD) AND THE MONTGOMERY-ASBERG (MADRS) SCALES AS OUTCOME MEASURES IN ANTIDEPRESSANT TRIALS Value in Health. 10: A302. DOI: 10.1016/S1098-3015(10)65096-6  0.058
1984 Artigas F, Suñol C, Tusell JM, Martínez E, Gelpí E. Determination of tryptamine in brain tissue by capillary gas chromatography mass spectrometry (selected ion monitoring). Biomedical Mass Spectrometry. 11: 142-4. PMID 6722286 DOI: 10.1002/bms.1200110309  0.056
1998 Artigas F. Pindolol augmentation: Single or multiple targets in the brain European Neuropsychopharmacology. 8: S97-S98. DOI: 10.1016/S0924-977X(98)80072-2  0.055
1982 Artigas F, Martinez E, Gelpi E. Neglected Practical Aspects in the Trace Analysis of Indoleamines and Related Metabolites by GC and GC/MS (Selected Ion Monitoring) Journal of Chromatographic Science. 20: 75-82. DOI: 10.1093/CHROMSCI/20.2.75  0.05
2016 Mitchell E, Klein SL, Argyropoulos KV, Sharma A, Chan RB, Toth JG, Barboza L, Bavley C, Bortolozzi A, Chen Q, Liu B, Ingenito J, Mark W, Dudakov J, Gross S, ... ... Artigas F, et al. Behavioural traits propagate across generations via segregated iterative-somatic and gametic epigenetic mechanisms. Nature Communications. 7: 11492. PMID 27173585 DOI: 10.1038/Ncomms11492  0.049
1988 Artigas F, Martínez E, Gelpí E. Organochlorine pesticides by negative ion chemical ionization. Brain metabolites of lindane. Biomedical & Environmental Mass Spectrometry. 16: 279-84. PMID 2468373  0.048
1988 Suñol C, Artigas F, Tusell JM, Gelpí E. High-performance liquid chromatography-fluorescence detection method for endogenous gamma-aminobutyric acid validated by mass spectrometric and gas chromatographic techniques. Analytical Chemistry. 60: 649-51. PMID 3382017  0.046
2013 Shin JY, Artigas F, Hobble C, Lee YS. Assessment of anthropogenic influences on surface water quality in urban estuary, northern New Jersey: multivariate approach. Environmental Monitoring and Assessment. 185: 2777-94. PMID 22773080 DOI: 10.1007/s10661-012-2748-0  0.046
1988 Artigas F, Martínez E, Camón L, Gelpí E, Rodríguez-Farré E. Brain metabolites of lindane and related isomers: identification by negative ion mass spectrometry. Toxicology. 49: 57-63. PMID 2453941  0.045
2005 Yang J, Artigas FJ, Wang Y. Mapping impervious surface for new jersey watershed management area 5 using aster imagery American Society For Photogrammetry and Remote Sensing - Annual Conference 2005 - Geospatial Goes Global: From Your Neighborhood to the Whole Planet. 2: 1177-1186.  0.045
1976 Segura J, Artigas F, Martinez E, Gelpi E. Adsorption of tryptophan metabolites from physiological fluids on XAD-2 and determination by single ion monitoring. Biomedical Mass Spectrometry. 3: 91-6. PMID 1268324  0.044
2013 Frazer A, Artigas F. Preclinical models of schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 2129. PMID 24369034 DOI: 10.1017/S1461145713001181  0.044
1983 Artigas F, Martínez E, Tusell JM, Suñol C, Gelpí E. On the metabolic origin of plasmatic indole-3-acetic acid in the rat. Biochemical Pharmacology. 32: 3251-4. PMID 6639690  0.04
2018 Salagre E, Arango C, Artigas F, Ayuso-Mateos JL, Bernardo M, Castro-Fornieles J, Bobes J, Desco M, Fañanás L, González-Pinto A, Haro JM, Leza JC, Mckenna PJ, Meana JJ, Menchón JM, et al. CIBERSAM: Ten years of collaborative translational research in mental disorders. Revista De Psiquiatria Y Salud Mental. PMID 30416047 DOI: 10.1016/J.RPSM.2018.10.001  0.039
2014 Schäfer KVR, Tripathee R, Artigas F, Morin TH, Bohrer G. Carbon dioxide fluxes of an urban tidal marsh in the Hudson-Raritan estuary Journal of Geophysical Research G: Biogeosciences. 119: 2065-2081. DOI: 10.1002/2014Jg002703  0.037
2011 Lefebvre A, Guiselin N, Barbet F, Artigas FL. Long-term hydrological and phytoplankton monitoring (19922007) of three potentially eutrophic systems in the eastern English Channel and the Southern Bight of the North Sea Ices Journal of Marine Science. 68: 2029-2043. DOI: 10.1093/Icesjms/Fsr149  0.037
2014 Yu CH, Huang L, Shin JY, Artigas F, Fan ZH. Characterization of concentration, particle size distribution, and contributing factors to ambient hexavalent chromium in an area with multiple emission sources. Atmospheric Environment (Oxford, England : 1994). 94: 701-708. PMID 25750579 DOI: 10.1016/J.Atmosenv.2014.06.004  0.037
2009 Artigas F, Elefante D, Marti A. Geographic information sharing: A regional approach in northern New Jersey, USA Information Polity. 14: 127-139. DOI: 10.3233/IP-2009-0165  0.036
2008 Jung K, Shin JY, Artigas F. Characteristics of ambient particulate pollutants near a heavily trafficked New Jersey Turnpike Proceedings of the Air and Waste Management Association's Annual Conference and Exhibition, Awma. 4: 2384-2396.  0.035
2010 Artigas F, Pechmann IC. Balloon imagery verification of remotely sensed Phragmites australis expansion in an urban estuary of New Jersey, USA Landscape and Urban Planning. 95: 105-112. DOI: 10.1016/j.landurbplan.2009.12.007  0.034
1982 Tusell JM, Suñol C, Artigas F, Martínez E, Gelpí E. Neurochemical studies on catecholamines and indoleamines by high-performance liquid chromatography with electrochemical detection Chromatographia. 16: 112-116. DOI: 10.1007/BF02258880  0.032
2006 Mansoor N, Slater L, Artigas F, Auken E. High-resolution geophysical characterization of shallow-water wetlands Geophysics. 71: B101-B109. DOI: 10.1190/1.2210307  0.031
1984 Tusell JM, Artigas F, Suñol C, Martínez E, Gelpí E. Comparison of high-performance liquid chromatography and gas chromatography-mass spectrometry for the analysis of indole-3-acetic acid in brain tissue. Journal of Chromatography. 306: 338-44. PMID 6715471  0.031
2008 Yang JS, Artigas FJ. Estimating impervious surfaces area of urban watersheds using ASTER data Journal of Environmental Informatics. 12: 1-8. DOI: 10.3808/jei.200800118  0.031
2011 Jung KH, Artigas F, Shin JY. Personal, indoor, and outdoor exposure to VOCs in the immediate vicinity of a local airport. Environmental Monitoring and Assessment. 173: 555-67. PMID 20237839 DOI: 10.1007/s10661-010-1404-9  0.03
1983 Martínez E, Artigas F, Suñol C, Tusell JM, Gelpí E. Liquid-chromatographic determination of indole-3-acetic acid and 5-hydroxyindole-3-acetic acid in human plasma. Clinical Chemistry. 29: 1354-7. PMID 6190588  0.028
1983 Adell A, Tusell JM, Artigas F, Martínez E, Suñol C, Gelpí E. Fluorometric Determination of Tryptophan and Its Brain Indoleamine Metabolites by Ion-Pair HPLC Journal of Liquid Chromatography. 6: 527-541. DOI: 10.1080/01483918308076065  0.027
2010 Shin JY, Jung KH, Artigas F. Monitoring of air toxic particulate pollutants from heavily trafficked New Jersey Turnpike: An urban community-wide project Proceedings of the Air and Waste Management Association's Annual Conference and Exhibition, Awma. 8: 6140-6150.  0.027
2014 Cappelacci MC, Alfaro TO, Artigas FL, Muñoz CS. Relationship between nutritional status, level of physical activity and psychomotor development in preschoolers | Relación entre estado nutricional, nivel de actividad física y desarrollo psicomotor en preescolares Nutricion Hospitalaria. 30: 1313-1318. DOI: 10.3305/nh.2014.30.6.7781  0.025
2015 Artigas F, Shin JY, Hobble C, Marti-Donati A, Schäfer KVR, Pechmann I. Long term carbon storage potential and CO2 sink strength of a restored salt marsh in New Jersey Agricultural and Forest Meteorology. 200: 313-321. DOI: 10.1016/j.agrformet.2014.09.012  0.025
2002 Holowczak RD, Artigas FJ, Chun SA, Cho JS, Stone HS. An experimental study on content-based image classification for satellite image databases Ieee Transactions On Geoscience and Remote Sensing. 40: 1338-1347. DOI: 10.1109/Tgrs.2002.800751  0.025
2008 De Lagrán MM, Bortolozzi A, Gispert J, Millán O, Artigas F, Fillat C, Dierssen MDM. Ageing in Down syndrome: DYRK1A as a candidate gene for cognitive decline | El envejecimiento en el síndrome de Down: Dyrk1A como gen candidato para el declive cognitivo Sd Revista Medica Internacional Sobre El Sindrome De Down. 12: 34-40.  0.024
2011 Jung KH, Artigas F, Shin JY. Seasonal gradient patterns of polycyclic aromatic hydrocarbons and particulate matter concentrations near a highway Atmosphere. 2: 533-552. DOI: 10.3390/atmos2030533  0.024
1990 Ortiz J, Martínez E, Gelpí E, Artigas F. Rapid non-enzymatic HPLC determination of total MHPG in human plasma. Life Sciences. 46: 239-46. PMID 2304368  0.022
2008 de Lagrán MM, Bortolozzi A, Gispert J, Millán O, Artigas F, Fillat C, del Mar Dierssen M. El envejecimiento en el síndrome de Down: Dyrk1A como gen candidato para el declive cognitivo Revista MéDica Internacional Sobre El SíNdrome De Down. 12: 34-40. DOI: 10.1016/S1138-2074(08)70024-1  0.021
2008 Martínez de Lagrán M, Bortolozzi A, Gispert J, Millán O, Artigas F, Fillat C, del Mar Dierssen M. Ageing in Down Syndrome: DYRK1A As a Candidate Gene for Cognitive Decline International Medical Review On Down Syndrome. 12: 34-40. DOI: 10.1016/S2171-9748(08)70039-4  0.021
2013 Abril G, Deborde J, Savoye N, Mathieu F, Moreira-Turcq P, Artigas F, Meziane T, Takiyama LR, de Souza MS, Seyler P. Export of 13C-depleted dissolved inorganic carbon from a tidal forest bordering the Amazon estuary Estuarine, Coastal and Shelf Science. 129: 23-27. DOI: 10.1016/J.Ecss.2013.06.020  0.018
1995 Gardier A, Jacquot C, Artigas F. Base neurobiologique du rôle des récepteurs 5-HTlA dans le mode d'action des antidépresseurs sérotoninergiques. MéDecine/Sciences. 11: 1407. DOI: 10.4267/10608/2322  0.016
2013 Chun SA, Artigas F. Tide gate sensor network as a forensic tool: Establishing facts during superstorm sandy Acm International Conference Proceeding Series. 277-278. DOI: 10.1145/2479724.2479771  0.016
2008 Artigas F. Introductory and Basic Aspects Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application. 1: 298-334. DOI: 10.1002/9783527619337.ch6  0.016
1988 Gelpi E, Abián J, Artigas F. Effects of sample matrix and high performance liquid chromatography eluent composition on the thermospray response for polar compounds. Rapid Communications in Mass Spectrometry : Rcm. 2: 232-5. PMID 2577833 DOI: 10.1002/rcm.1290021105  0.015
2006 Artigas FJ, Yang J. Spectral discrimination of Marsh vegetation types in the New Jersey Meadowlands, USA Wetlands. 26: 271-277. DOI: 10.1672/0277-5212(2006)26[271:SDOMVT]2.0.CO;2  0.013
2005 Artigas FJ, Yang JS. Hyperspectral remote sensing of marsh species and plant vigour gradient in the new Jersey Meadowlands International Journal of Remote Sensing. 26: 5209-5220. DOI: 10.1080/01431160500218952  0.011
1984 Artigas F, Martinez E, Tusell JM, Suñol C, Gelpí E. Improved liquid-chromatographic determination of 5-hydroxyindoles. Clinical Chemistry. 30: 160-1. PMID 6690136  0.011
2015 Chun SA, Artigas F. Participatory environmental planning platform Emerging Issues, Challenges, and Opportunities in Urban E-Planning. 46-68. DOI: 10.4018/978-1-4666-8150-7.ch003  0.01
2015 Missio JC, Renau RM, Artigas FC, Cornejo JC. Sugar-and-acid profile of penjar tomatoes and its evolution during storage Scientia Agricola. 72: 314-321. DOI: 10.1590/0103-9016-2014-0311  0.01
2014 Artigas F. Spatial analytics for open government data Acm International Conference Proceeding Series. 357-358. DOI: 10.1145/2612733.2612736  0.01
2013 Artigas F, Chun SA. Visual analytics for open government data Acm International Conference Proceeding Series. 298-299. DOI: 10.1145/2479724.2479729  0.01
2011 Miloslavich P, Klein E, Díaz JM, Hernández CE, Bigatti G, Campos L, Artigas F, Castillo J, Penchaszadeh PE, Neill PE, Carranza A, Retana MV, Díaz de Astarloa JM, Lewis M, Yorio P, et al. Marine biodiversity in the Atlantic and Pacific coasts of South America: knowledge and gaps. Plos One. 6: e14631. PMID 21304960 DOI: 10.1371/journal.pone.0014631  0.01
2008 Celada P, Castañé A, Adell A, Artigas F. Experimental Research Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application. 1: 449-489. DOI: 10.1002/9783527619337.ch9  0.01
2006 Adam NR, Atluri V, Chun SA, Artigas F, Bora I, Ceberio B. Constituent-centric municipal government coalition portal Acm International Conference Proceeding Series. 151: 365-366. DOI: 10.1145/1146598.1146704  0.01
2001 Holowczak RD, Chun SA, Artigas FJ. Customized geospatial workflows for E-government services Proceedings of the Acm Workshop On Advances in Geographic Information Systems. 64-69.  0.01
2000 Artigas F, Pérez V, Alvarez E. Reply Biological Psychiatry. 47: 846-847. DOI: 10.1016/S0006-3223(00)00233-X  0.01
1980 Daniel Riesco C, San José Garagarza JM, Domenech Delgado LJ, Artigas F. [Delayed cardiac rupture after myocardial infarct. Rupture of ventricular aneurysm and attempt of a surgical correction]. Revista EspañOla De CardiologíA. 33: 185-9. PMID 7403622  0.01
Hide low-probability matches.